Date published: 2025-9-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

UNC93A Inhibitors

Chemical inhibitors of UNC93A disrupt its role in the endosomal system, primarily by targeting processes essential for the trafficking and sorting of toll-like receptors. Bafilomycin A1 and Concanamycin A inhibit the vacuolar-type H+ ATPase (V-ATPase). This enzyme is critical for the acidification of endosomes, a process that is necessary for the proper function of UNC93A. By preventing this acidification, these inhibitors compromise the environment required for UNC93A to facilitate the correct localization of toll-like receptors. Similarly, Monensin, by acting as an ionophore, disrupts endosomal ion gradients, which also affects the pH and ion homeostasis critical for UNC93A's role in toll-like receptor sorting. Filipin III works differently by disrupting lipid rafts through cholesterol binding, which can impair the localization of toll-like receptors within endosomes, a process that UNC93A assists in orchestrating.

Dynasore and Dyngo-4a, both dynamin inhibitors, impede the scission of newly formed endocytic vesicles from the plasma membrane, which is essential for endocytosis. MiTMAB also targets dynamin but by inhibiting its GTPase activity, crucial for vesicle scission during endocytosis. These disruptions lead to an overall inhibition in the endosomal pathway, thereby affecting UNC93A functionality due to the impaired delivery of toll-like receptors to endosomes. Furthermore, Pitstop 2 and Chlorpromazine block clathrin-mediated endocytosis, which is another pathway that UNC93A relies on for sorting toll-like receptors. By impeding the formation of clathrin-coated vesicles, these inhibitors disrupt a critical step in endosomal trafficking. Additionally, Genistein and Tyrphostin AG 1478, as tyrosine kinase inhibitors, can obstruct the phosphorylation of proteins involved in endocytic trafficking, which is a key regulatory step for maintaining the endosomal sorting machinery that UNC93A is a part of. Each of these chemical inhibitors, by targeting different aspects of the endosomal pathway and vesicle trafficking, can directly or indirectly lead to the functional inhibition of UNC93A.

SEE ALSO...

Items 31 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING